Drug Information
| Drug General Information | |||||
|---|---|---|---|---|---|
| Drug ID |
D0U7WF
|
||||
| Former ID |
DIB018489
|
||||
| Drug Name |
16,16-dimethyl-PGE2
|
||||
| Synonyms |
16,16-dimethylprostaglandin E2
|
||||
| Drug Type |
Small molecular drug
|
||||
| Indication | Discovery agent | Investigative | [539226] | ||
| Structure |
|
Download2D MOL |
|||
| Formula |
C22H36O5
|
||||
| InChI |
InChI=1S/C22H36O5/c1-4-5-14-22(2,3)20(25)13-12-17-16(18(23)15-19(17)24)10-8-6-7-9-11-21(26)27/h6,8,12-13,16-17,19-20,24-25H,4-5,7,9-11,14-15H2,1-3H3,(H,26,27)/b8-6-,13-12+/t16-,17-,19-,20-/m1/s1
|
||||
| InChIKey |
QAOBBBBDJSWHMU-WMBBNPMCSA-N
|
||||
| PubChem Compound ID | |||||
| PubChem Substance ID |
4265999, 11038723, 14780130, 15990197, 22395646, 24893214, 26754817, 26754818, 39316483, 47211768, 48258966, 50110788, 56459057, 56459353, 77442172, 91703663, 92309781, 99234253, 99300695, 99302213, 104046444, 104242283, 113858994, 135651380, 162227826, 163685804, 177748431, 179205571, 198989304, 226969995, 241376771, 250132932, 252157723, 252455505, 252457331
|
||||
| Target and Pathway | |||||
| Target(s) | Prostaglandin E2 receptor EP3 subtype | Target Info | Agonist | [534478] | |
| Prostaglandin E2receptor, EP2 subtype | Target Info | Agonist | [534478] | ||
| Prostaglandin E2 receptor, EP4 subtype | Target Info | Agonist | [534478] | ||
| KEGG Pathway | Calcium signaling pathway | ||||
| cAMP signaling pathway | |||||
| Neuroactive ligand-receptor interaction | |||||
| Regulation of lipolysis in adipocytes | |||||
| Pathways in cancerhsa04024:cAMP signaling pathway | |||||
| Inflammatory mediator regulation of TRP channels | |||||
| Renin secretion | |||||
| Pathways in cancerhsa04080:Neuroactive ligand-receptor interaction | |||||
| Pathways in cancer | |||||
| References | |||||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.